News

CompleGen, Inc. and Temple University School of Medicine Awarded NIH Grant to Study Effectiveness of Allosteric Inhibitors in Acute Lung Injury
Seattle, WA and Philadelphia, PA [September 17, 2012]
  Full Press Release

CompleGen Announces Successful Delivery of Its XenoGene™ Technology to Boehringer Ingelheim for Drug Discovery Under a Non-Exclusive Agreement.
Seattle, WA and Ridgefield, CT [January 17, 2012]
  Full Press Release

CompleGen, Inc. and DuPont Crop Protection Announce Research Agreement
Seattle, WA and Wilmington, DE [May 11, 2005]
  Full Press Release

CompleGen and DuPont Crop Protection Sign Agreement to Allow CompleGen Access to a Large Chemical Compound Library
Seattle, WA and Wilmington, DE [September 24, 2004]   Full Press Release

CompleGen and Berlex Enter Into a Drug Discovery Agreement
Seattle [April 7, 2003]   Full Press Release

CompleGen Awarded SBIR Grant to Discover Novel Anti-Parasitic Drugs
Seattle [May 6, 2003]   Full Press Release

CompleGen Announces Delivery of Targeted Cell-Based Assays to DuPont Crop Protection
Seattle [March 27, 2003]   Full Press Release

CompleGen receives SBIR award to discover nonhormonal contraceptives.
Seattle [March 1, 2002]   Full Press Release

CompleGen and Berlex Biosciences begin drug discovery collaboration.
Seattle [March 7, 2002] Full Press Release

CompleGen awarded SBIR grant to discover novel anti-malaria drugs.
Seattle [March 15, 2002]  Full Press Release